Highlights from the Society of Urologic Oncology (SUO) 2024

The 25th Annual Meeting of the Society of Urologic Oncology (SUO) was organized by the Society of Urologic Oncology (SUO) in collaboration with WJ Weiser and Associates, Inc. The event took place from December 4th to 6th, 2024 in Dallas, Texas, USA.

The Society of Urologic Oncology sponsored a highly interactive meeting where attendees participated in discussions led by internationally renowned urologic oncologists, medical oncologists, and scientists. State-of-the-art translational topics on prostate, kidney, and bladder cancer, as well as strategies in urologic oncology, were covered. A half-day session was held on Wednesday morning focusing on Clinical Research, aimed at ensuring that fellows were equipped with the necessary tools to engage in clinical trials upon graduation and to facilitate their involvement in the SUO-CTC.

The mission of the Society of Urologic Oncology (SUO) was to enable qualified members primarily interested in the care of patients with malignant genitourinary (GU) diseases to meet for the purpose of discussion, development, and implementation of ideas to improve care. The organization aimed to stimulate research and teaching in urologic oncology, disseminate the principles of urologic oncology to the medical profession at large, bring urologists into a society focused on malignant disease, be the most qualified organization on matters of urologic oncology, and standardize fellowship training in urologic oncology.

Healthcare Professionals and Organizations Shared on Social Media about This Conference:

Juan José Andino

“Francisco Rodríguez-Covarrubias discussed the differences in treatment paradigms in Latin America and importance of guidelines being developed with consideration for resources available in different settings.”

Zeyad Schwen

“Extremely proud of Eiftu, Jason Scovell, Ross Liao and all our outstanding residents and fellows who presented their Cleveland Clinic Urology research at SUO24 in Dallas.”

Udit Singhal

“‘How do we design clinical trials so that they don’t fail?’ – great overview by Kristian Stensland leveraging his implementation background to give us insight at SUO 2024 Symposium.”

Eran Maina

“Using single-cell RNA sequencing, our group found that M2-like macrophage gene signature is associated with poor prognosis in MIBC. Always excited and grateful to learn under the mentorship of Laura Bukavina and the whole Cleveland Clinic Urology team!”

Pedro F. S. Freitas

“Great time at SUO 2024: learning, latest clinical trials, meeting friends, and making new ones! Celebrating with all generations of Desai Sethi Urology Institute.”

Laura Bukavina

“Always a great time in the OR Jason Scovell catch his SUO 2024 poster tomorrow also major FOMO I couldn’t be there for our incredible fellow presentation Betty Wang in bladder cancer and role of tumor infiltrating neutrophils.”

Zeyad Schwen

“Trinity J. Bivalacqua giving a fantastic overview of sexual dysfunction after cystectomy at SUO2024.

Before: Counsel
During: Spare
After: Treat.”

Chirag Doshi

“With a sensitivity of 90% and NPV of 94% at 12 months, CxBladder Monitor can potentially delay cystoscopy. Huge thanks to my amazing PI, Sia Daneshmand, and to my wonderful collaborators Anosh Dadabhoy, Farshad Sheybaee, Leilei Xia for all their support.”

Sabika Sadiq

“From SUO 2024 to DSUI holiday party, grateful to have an incredible mentor.”

Aditya Bagrodia

“Capping off an awesome visit to ⁦Moffitt Urologic Oncology Fellowship with travel buddies to SUO2024⁩! Can’t wait to be back to the old stomping grounds and see my ⁦UT Southwestern Urology⁩ family!”

Ruth Belay

“Old friendships and new connections—building together at SUO 2024.”

Matthew Hayn

“Who are the 2% of urologists who don’t think that smoking contributes to urologic diseases.”

Reuben Ben-David

“Thank you YUO for the opportunity to present our work on ctDNA conversion dynamics and undetectable precystectomy ctDNA at the SUO 2024! Conversion dynamics matter and they predict different disease outcomes!”